Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1713889

	registered interest
	date	25/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	National Learning Disability Board
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when the National Learning Disability Board last met.
	tabling member constituency	Romsey and Southampton North
	tabling member printed	Caroline Nokes
	uin	23729
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>The final meeting of the National Learning Disability Board took place on 19 July 2016. More information is available at the following link:</p><p><a href="https://www.gov.uk/government/groups/learning-disability-programme-board#minutes" target="_blank">https://www.gov.uk/government/groups/learning-disability-programme-board#minutes</a></p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 30/04/2024 16:48:01 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4048 label Biography information for Caroline Nokes

1713890

	registered interest
	date	25/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Learning Disability: Nurses
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many learning disability nurses there (a) are and (b) were in each of the last five years.
	tabling member constituency	Romsey and Southampton North
	tabling member printed	Caroline Nokes
	uin	23730
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>NHS England publishes monthly Hospital and Community Health Services workforce statistics for England. These include staff working for hospital trusts and core organisations, but excludes staff working for other providers such as in primary care, general practice, or social care. This data is drawn from the Electronic Staff Record, the human resources system for the National Health Service. The statistics are available at the following link:</p><p> </p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/nhs-workforce-statistics" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/nhs-workforce-statistics</a></p><p> </p><p>A large proportion of learning disability nurses work outside NHS trusts, and we do not hold data on where they work. However, the Nursing and Midwifery Council publishes data on the number of nurses on the register across the United Kingdom, which will include nurses employed in other settings, such as education. Data is available in the Fields of Practice sheet in the permanent register data tables, at the following link:</p><p><a href="https://www.nmc.org.uk/about-us/reports-and-accounts/registration-statistics/" target="_blank">https://www.nmc.org.uk/about-us/reports-and-accounts/registration-statistics/</a></p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 23731 question first answered 30/04/2024 09:48:48 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4048 label Biography information for Caroline Nokes

1713891

	registered interest
	date	25/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Learning Disability: Nurses
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many and what proportion of learning disability nurses are in senior leadership roles.
	tabling member constituency	Romsey and Southampton North
	tabling member printed	Caroline Nokes
	uin	23731
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>NHS England publishes monthly Hospital and Community Health Services workforce statistics for England. These include staff working for hospital trusts and core organisations, but excludes staff working for other providers such as in primary care, general practice, or social care. This data is drawn from the Electronic Staff Record, the human resources system for the National Health Service. The statistics are available at the following link:</p><p> </p><p><a href="https://digital.nhs.uk/data-and-information/publications/statistical/nhs-workforce-statistics" target="_blank">https://digital.nhs.uk/data-and-information/publications/statistical/nhs-workforce-statistics</a></p><p> </p><p>A large proportion of learning disability nurses work outside NHS trusts, and we do not hold data on where they work. However, the Nursing and Midwifery Council publishes data on the number of nurses on the register across the United Kingdom, which will include nurses employed in other settings, such as education. Data is available in the Fields of Practice sheet in the permanent register data tables, at the following link:</p><p><a href="https://www.nmc.org.uk/about-us/reports-and-accounts/registration-statistics/" target="_blank">https://www.nmc.org.uk/about-us/reports-and-accounts/registration-statistics/</a></p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 23730 question first answered 30/04/2024 09:48:48 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4048 label Biography information for Caroline Nokes

1713892

	registered interest
	date	25/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Autism and Learning Disability: Training
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if she will make an estimate of the number of health and adult social care staff that will undertake the second part of tier (a) one and (b) two of the Oliver McGowan Mandatory Training on Learning Disability and Autism in the next three years.
	tabling member constituency	Romsey and Southampton North
	tabling member printed	Caroline Nokes
	uin	23732
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>We have provided estimates of the number of health and adult social care staff that would undertake Tier 1 and Tier 2 of the Oliver McGowan Mandatory Training in our consultation stage impact assessment. This assessment was published as part of the public consultation on the Oliver McGowan Code of Practice. The impact assessment and wider public consultation are available, respectively, at the following two links:</p><p><a href="https://assets.publishing.service.gov.uk/media/649a8c399e7a8b0013932bec/impact-assessment-oliver-mcgowan-draft-code-of-practice.pdf" target="_blank">https://assets.publishing.service.gov.uk/media/649a8c399e7a8b0013932bec/impact-assessment-oliver-mcgowan-draft-code-of-practice.pdf</a></p><p><a href="https://www.gov.uk/government/consultations/oliver-mcgowan-draft-code-of-practice/oliver-mcgowan-draft-code-of-practice-on-statutory-learning-disability-and-autism-training" target="_blank">https://www.gov.uk/government/consultations/oliver-mcgowan-draft-code-of-practice/oliver-mcgowan-draft-code-of-practice-on-statutory-learning-disability-and-autism-training</a></p><p>For healthcare, we estimated that over the first three years of training roll-out, 1,036,000 staff would be trained at Tier 1 level, and 1,186,000 staff would be trained at Tier 2 level. For adult social care, over the same period, we estimated that 840,000 staff would be trained at Tier 1 level, and 492,000 staff would be trained at Tier 2 level. In addition, over 1.7 million people have already completed the first part of Oliver McGowan Mandatory Training on Learning Disability and Autism, an e-learning package.</p><p>The final stage impact assessment incorporates additional evidence on the number of staff expected to undertake training, which was provided by organisations through the public consultation. The final assessment will be published in due course.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 30/04/2024 10:04:00 answering member 4492 label Biography information for Maria Caulfield
	tabling member	4048 label Biography information for Caroline Nokes

1713908

	registered interest
	date	25/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Liver Cancer: Mortality Rates
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether she has made an estimate of expected liver cancer mortality rates by the end of 2025.
	tabling member constituency	East Londonderry
	tabling member printed	Mr Gregory Campbell
	uin	23699
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>No estimate has been made of expected liver cancer mortality rates by the end of 2025. The care of and treatment for patients with cancer, including liver cancer, is a priority for the Government. Early diagnosis of liver cancer is critical to improving rates of survival. NHS England’s Early Diagnosis of Liver Cancer Programme is contributing to the NHS Long Term Plan’s commitment to diagnose 75% of all cancers at stage one or two by 2028. This programme includes three workstreams: improving liver surveillance programmes; community liver health checks pilots; and primary care pilots. Identifying those at risk and ensuring patients are tested and referred to a surveillance programme, where necessary, will lead to improved patient outcomes.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 30/04/2024 09:55:44 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	1409 label Biography information for Mr Gregory Campbell

1713932

	registered interest
	date	25/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Clinical Trials
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the paper entitled The Future of Clinical Research Delivery: 2022 to 2025 implementation plan, published on 30 June 2022, what progress has been made on the Find, Recruit and Follow-up service for clinical trials.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	23739
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>Since publication of the Future of Clinical Research Delivery, we have developed early versions of several products as part of the Find, Recruit and Follow-up Service, to deliver secure data enabled study feasibility and recruitment within established governance and legal requirements, across England and other parts of the United Kingdom.</p><p> </p><p>These products include: NHS England’s DigiTrials self-service feasibility tool, which identifies suitable locations for studies by establishing where the largest groupings of eligible people are based; NHS England’s DigiTrials recruitment service, which is currently in its second phase of pilots and will enable the National Health Service to more easily approach patients about research relevant to them; the Medicines and Healthcare products Regulatory Agency’s Clinical Research Practice Datalink, which allows participating general practices to identify potentially eligible patients for relevant studies more easily; and the Be Part of Research registry, which allows people to proactively register their interest in participating in research.</p><p> </p><p>These tools have been developed to increase the efficiency and effectiveness of the clinical research process, and also improve our ability to widen access to research opportunities, increase the resilience and sustainability of the healthcare system, and reduce the burden on the NHS workforce.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 30/04/2024 10:48:51 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4124 label Biography information for Chi Onwurah

1713933

	registered interest
	date	25/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Clinical Trials: Contracts
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the policy paper entitled Full government response to the Lord O'Shaughnessy review into commercial clinical trials, last updated on 8 December 2023, what her Department's planned timetable is for expanding the national contract value review programme to phase 1 and 2a clinical trials.
	tabling member constituency	Newcastle upon Tyne Central
	tabling member printed	Chi Onwurah
	uin	23740
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>The National Contract Value Review (NCVR) process applies to commercial clinical studies. NHS England is working in partnership with the devolved administrations, the National Institute for Health and Care Research, and other partners, to pilot the use of the NCVR process for phase I and IIa of commercial clinical trials. The ambition is to make the use of NCVR for phase I and IIa of commercial clinical trials mainstream from October 2024.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 30/04/2024 09:57:50 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4124 label Biography information for Chi Onwurah

1713936

	registered interest
	date	25/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medicines and Healthcare Products Regulatory Agency: Accountability
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how the Medicines and Healthcare products Regulatory Agency is held accountable for its decisions.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	23760
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) performs the functions of my Rt hon. Friend, the Secretary of State for Health and Social Care, under United Kingdom legislation, relating to the regulation of medicines, medical devices, and blood products for transfusion. The MHRA also performs the functions of my Rt hon. Friend, the Secretary of State for Health and Social Care in relation to the standardisation and control of biological medicines including vaccines, blood products, and other substances which cannot be characterised chemically, and which require special testing measures to ensure their safety and efficacy.</p><p>My Rt hon. Friend, the Secretary of State for Health and Social Care has ministerial responsibility for, and oversight of, the MHRA’s delivery and performance. The MHRA seeks ministerial agreement for policy and legislative framework changes. Ministers are not involved in individual decisions made by the MHRA. The MHRA is held to account through regular established mechanisms including quarterly and annual accountability reviews. A framework agreement between the Department and the MHRA also sets out the governance structure within which both parties operate, with further information available at the following link:</p><p><a href="https://www.gov.uk/government/publications/dh-and-mhra-framework-agreement/framework-agreement-between-dhsc-and-the-medicines-and-healthcare-products-regulatory-agency" target="_blank">https://www.gov.uk/government/publications/dh-and-mhra-framework-agreement/framework-agreement-between-dhsc-and-the-medicines-and-healthcare-products-regulatory-agency</a></p><p>The MHRA also publishes performance figures each month, as well as its annual report and accounts, and the minutes of the latest Annual Accountability Review with the MHRA is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/annual-accountability-review-mhra/annual-accountability-review-minutes-2022-to-2023-3-july-2023" target="_blank">https://www.gov.uk/government/publications/annual-accountability-review-mhra/annual-accountability-review-minutes-2022-to-2023-3-july-2023</a></p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 23761 question first answered 30/04/2024 09:52:08 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4471 label Biography information for Rachael Maskell

1713937

	registered interest
	date	25/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medicines and Healthcare Products Regulatory Agency
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps is she taking to review the decisions of the Medicines and Healthcare products Regulatory Agency.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	23761
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) performs the functions of my Rt hon. Friend, the Secretary of State for Health and Social Care, under United Kingdom legislation, relating to the regulation of medicines, medical devices, and blood products for transfusion. The MHRA also performs the functions of my Rt hon. Friend, the Secretary of State for Health and Social Care in relation to the standardisation and control of biological medicines including vaccines, blood products, and other substances which cannot be characterised chemically, and which require special testing measures to ensure their safety and efficacy.</p><p>My Rt hon. Friend, the Secretary of State for Health and Social Care has ministerial responsibility for, and oversight of, the MHRA’s delivery and performance. The MHRA seeks ministerial agreement for policy and legislative framework changes. Ministers are not involved in individual decisions made by the MHRA. The MHRA is held to account through regular established mechanisms including quarterly and annual accountability reviews. A framework agreement between the Department and the MHRA also sets out the governance structure within which both parties operate, with further information available at the following link:</p><p><a href="https://www.gov.uk/government/publications/dh-and-mhra-framework-agreement/framework-agreement-between-dhsc-and-the-medicines-and-healthcare-products-regulatory-agency" target="_blank">https://www.gov.uk/government/publications/dh-and-mhra-framework-agreement/framework-agreement-between-dhsc-and-the-medicines-and-healthcare-products-regulatory-agency</a></p><p>The MHRA also publishes performance figures each month, as well as its annual report and accounts, and the minutes of the latest Annual Accountability Review with the MHRA is available at the following link:</p><p><a href="https://www.gov.uk/government/publications/annual-accountability-review-mhra/annual-accountability-review-minutes-2022-to-2023-3-july-2023" target="_blank">https://www.gov.uk/government/publications/annual-accountability-review-mhra/annual-accountability-review-minutes-2022-to-2023-3-july-2023</a></p> answering member constituency Pendle answering member printed Andrew Stephenson grouped question UIN 23760 question first answered 30/04/2024 09:52:08 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4471 label Biography information for Rachael Maskell

1714010

	registered interest
	date	25/04/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Shortages
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what assessment they have made of shortages in the supply of prescription drugs.
	tabling member printed	The Lord Bishop of Southwark
	uin	HL4117
	answer	answer is ministerial correction date of answer 30/04/2024 answer text <p>There are approximately 14,000 medicines licensed for supply in the United Kingdom, and the overwhelming majority are in good supply. The medicine supply chain is complex, global, and highly regulated, and supply issues can be caused by a range of factors. For example, suppliers can encounter manufacturing problems, difficulty accessing raw materials, and surges in demand. These are commonly cited as the drivers of the recent supply issues, which have affected many countries, not just the UK.</p><p>Whilst we can’t always prevent supply issues, we have a range of well-established tools and processes to mitigate risks to patients. These include close and regular engagement with suppliers, use of alternative strengths or forms of a medicine to allow patients to remain on the same product, expediting regulatory procedures, sourcing unlicensed imports from abroad, adding products to the restricted exports and hoarding list, use of Serious Shortage Protocols, and issuing National Health Service communications to provide management advice and information on the issue to healthcare professionals, so they can advise and support their patients.</p> answering member printed Lord Markham question first answered 30/04/2024 11:37:26 answering member 4948 label Biography information for Lord Markham
	tabling member	4345 label Biography information for The Lord Bishop of Southwark